NERM
CI icon

New England Research & Management’s Cigna CI Stock Holding History

New England Research & Management’s Portfolio CI Stock Details CI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,920
Closed -$671K – 166
2021
Q4 		$671K Sell
2,920
-2,630
-47% -$559K 0.32% 93
2021
Q3 		$1.11M Buy
5,550
+3,075
+124% +$669K 0.58% 61
2021
Q2 		$587K Hold
2,475
– – 0.3% 107
2021
Q1 		$598K Buy
+2,475
New +$552K 0.33% 95

Other funds holding CI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New England Research & Management's CI Position: Q1 2022 in Review

New England Research & Management sold out of Cigna (CI) in Q1 2022, closing a stake of 2,920 shares — an estimated $671K sold.

New England Research & Management first reported a position in CI in Q1 2021 and held it in 4 quarters. The position peaked at $1.11M in Q3 2021. 1,373 funds tracked by Wall St. Rank hold CI as of Q1 2022.

  • New England Research & Management reported no remaining Cigna position as of Q1 2022 after selling out during the quarter.
  • New England Research & Management sold 2,920 Cigna shares in Q1 2022, an estimated $671K.
  • New England Research & Management first reported a position in Cigna in Q1 2021 and held it in 4 quarters.
  • New England Research & Management's Cigna position peaked at $1.11M in Q3 2021.
  • 1,373 funds tracked by Wall St. Rank held Cigna as of Q1 2022.

Based on New England Research & Management's 13F filing for Q1 2022, filed 20 Apr 2022.